Motif BioSciences, Inc. Reports Half-Year 2017 Financial Results And Operational Progress Post author:Sam Post published:September 28, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Arno Therapeutics Is Shuttering Its Doors December 21, 2017 Boehringer Ingelheim Initiates Phase IIa Study Of Compound Acquired From Pharmaxis In Debilitating Liver Disease NASH August 24, 2017 Run by Former Genentech Employees, Bay Area's Denali Seeks $100M IPO November 13, 2017
Boehringer Ingelheim Initiates Phase IIa Study Of Compound Acquired From Pharmaxis In Debilitating Liver Disease NASH August 24, 2017